Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression

被引:10
|
作者
Delhem, Nadira [1 ]
Cottrez, Francoise [2 ]
Carpentier, Arnaud [1 ,3 ]
Miroux, Celine [1 ]
Morales, Olivier [1 ]
Francois, Violaine [1 ]
Groux, Herve [2 ]
Auriault, Claude [4 ]
Pancre, Veronique [1 ]
机构
[1] Inst Biol Lille, Lab Immunopathol Canc Viroinduits, UMR 8161, Lille, France
[2] Les Cyclades, Immunosearch, Grasse, France
[3] Inst Cochin Genet Mol, Immunol Lab, UPREZ 1833, F-75014 Paris, France
[4] CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, Sophia Antipoli, France
关键词
HCV; hepatocarcinoma; T lymphocyte; cirrhosis; fibrosis;
D O I
10.1684/bdc.2008.0752
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatitis C virus (HCV) becomes chronic in about 85% of infected individuals, whereas only 15% of infected people clear spontaneously the virus. The progression of hepatitis C to chronic status is associated to a profound down-regulation of CD4 and CD8 multispecific immune response. This immune defect may participate to the immune tolerance of VHC and consequently to its persistence. Recent findings indicate that T regulatory cells as Tr1 play an inhibitory role on T helper responses notably in the context of auto-immune or inflammatory disorders. The existence of immunosuppressive mechanisms supported by Tr1 lymphocytes and their IL-10 production represent an attractive hypothesis. We have previously evaluated the existence of regulatory T cells (Tr1) via high production of IL-70, in liver biopsies of three well-defined cohorts of HCV-1b infected patients. To this purpose, we compared liver biopsies of chronically infected patients including patients without liver lesions, with cirrhosis and with hepatocellular carcinoma (HCC). Using quantitative real time PCR, the results obtained
引用
收藏
页码:1029 / 1038
页数:10
相关论文
共 50 条
  • [31] Methylenetetrahydrofolate reductase C677T polymorphism and liver fibrosis progression in patients with recurrent hepatitis C
    Toniutto, Pierluigi
    Fabris, Carlo
    Falleti, Edmondo
    Cussigh, Annarosa
    Fontanini, Elisabetta
    Bitetto, Davide
    Fornasiere, Ezio
    Minisini, Rosalba
    De Feo, Tullia
    Marangoni, Francesca
    Pirisi, Mario
    [J]. LIVER INTERNATIONAL, 2008, 28 (02) : 257 - 263
  • [32] Metabolic cofactors play an important role in fibrosis progression in initially mild chronic hepatitis C
    Alberti, A
    Vario, A
    Boccato, S
    Ferrari, A
    Benvegnu, L
    Gatta, A
    [J]. JOURNAL OF HEPATOLOGY, 2002, 36 : 96 - 96
  • [33] The Role of Regulatory T Lymphocytes in Amyotrophic Lateral Sclerosis
    Beers, David R.
    Zhao, Weihua
    Appel, Stanley H.
    [J]. JAMA NEUROLOGY, 2018, 75 (06) : 656 - 658
  • [34] Progression of fibrosis in hepatitis C with and without schistosomiasis: Correlation with serum markers of fibrosis
    Kamal, SM
    Turner, B
    He, Q
    Rasenack, J
    Bianchi, L
    Al Tawil, A
    Nooman, A
    Massoud, M
    Koziel, MJ
    Afdhal, NH
    [J]. HEPATOLOGY, 2006, 43 (04) : 771 - 779
  • [35] Clinical Advances in Fibrosis Progression of Chronic Hepatitis B and C
    Wu, Ye-Jiao
    Xu, Ming-Yi
    Lu, Lun-Gen
    [J]. JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2014, 2 (04) : 222 - 227
  • [36] Response to Fibrosis progression in patients treated for hepatitis C recurrence
    Dhanasekaran, Renumathy
    Sanchez, William
    Charlton, Michael
    [J]. LIVER INTERNATIONAL, 2015, 35 (12) : 2625 - 2625
  • [37] Morphogenesis of the liver fibrosis development and progression in chronic hepatitis C
    Shishkin, M. A.
    [J]. ZAPOROZHYE MEDICAL JOURNAL, 2015, (02) : 63 - 65
  • [38] THE IMPACT OF AGE ON FIBROSIS PROGRESSION IN CHRONIC HEPATITIS C PATIENTS
    Gountas, I.
    Vana, S.
    Delladetsima, I.
    Tassopoulos, N.
    Papatheodoridis, G.
    Hatzakis, A.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 64 : S459 - S460
  • [39] Progression of fibrosis in untreated patients with hepatitis C virus infection
    Lagging, LM
    Westin, J
    Svensson, E
    Aires, N
    Dhillon, AP
    Lindh, M
    Wejstål, R
    Norkrans, G
    [J]. LIVER, 2002, 22 (02): : 136 - 144
  • [40] Individualizing the prediction of fibrosis progression in chronic hepatitis C.
    Wong, JB
    Poynard, T
    [J]. HEPATOLOGY, 2004, 40 (04) : 677A - 677A